http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103169701-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f158405cc30d8693d6664b879a8582b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7347d4c0860890e691df815af26746d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_babf976f27f89fee90007e6d37db6ec3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2778aae1f9e1e999fd249ac46367d88c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c30fe5dca70644b03418e209e18ba01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c99874f1d0dc3b0a81ecdd418083b46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_760a2f25351a3771da9e05c6b6e0dcd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22f9c027010fdd4c3a28a11d3befc7e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9242551d7ccec3feec3ef4bd201bf11
publicationDate 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103169701-B
titleOfInvention Telmisartan amlodipine double-layer tablet and preparation method thereof
abstract The invention relates to a telmisartan amlodipine double-layer tablet and a preparation method of the telmisartan amlodipine double-layer tablet. The double-layer tablet comprises a telmisartan tablet layer and an amlodipine tablet layer; the telmisartan tablet layer contains telmisartan and pharmaceutically acceptable auxiliary material; the amlodipine tablet layer contains amlodipine and pharmaceutically acceptable auxiliary material; the telmisartan and the auxiliary material of the amlodipine tablet layer do not contain sorbitol and milk sugar; and the telmisartan tablet layer prepares tablet particles by a top-spraying fluidized bed. The telmisartan amlodipine double-layer tablet preparation disclosed by the invention is good in moldability, high in drug stability, high in bioavailability, simple in preparation process, and low in production cost; and the stability of the product is improved.
priorityDate 2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453267806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450109460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454611257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86752717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453327642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412232975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21862953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21917895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12820921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24836924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452932536

Total number of triples: 73.